Trial Profile
Once a Day Immunosuppression Regimen: Outcomes and Compliance
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Jan 2023
Price :
$35
*
At a glance
- Drugs Azathioprine (Primary) ; Tacrolimus (Primary) ; Mycophenolic acid
- Indications Renal transplant rejection
- Focus Adverse reactions
- 30 Dec 2022 Planned number of patients changed from 100 to 80.
- 30 Dec 2022 Planned End Date changed from 1 Dec 2023 to 1 Dec 2025.
- 30 Dec 2022 Planned primary completion date changed from 1 Jul 2023 to 1 Dec 2024.